Absence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its function

FEBS Letters

Volumn 531, Issue 2, 2002, Pages 290-294

  Song, Z H ^a   Feng, Wenke ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cannabinoid; G protein coupled receptor; Marijuana; Mutagenesis; Transmembrane domain

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP; FORSKOLIN; META TYROSINE; PROLINE;

AGONIST; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; LIGAND BINDING; MUTAGENESIS; MUTATION; PLASMID; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE; CONSERVED SEQUENCE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HUMANS; LIGANDS; PROLINE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TYROSINE;

CANNABIS SATIVA;

EID: 0037032472     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03537-8     Document Type: Article

References (29)

1. Hollister L.E. Pharmacol. Rev. 38:1986;1-20.
2. Gaoni Y., Mechoulam R. J. Am. Chem. Soc. 86:1964;1646-1647.
3. Mechoulam R., Feigenbaum J.J., Lander N., Segal M., Jarbe T.U., Hiltunen A.J., Consroe P. Experientia. 44:1988;762-764.
4. Melvin L.S., Milne G.M., Johnson M.R., Subramaniam B., Wilken G.H., Howlett A.C. Mol. Pharmacol. 44:1993;1008-1015.
5. Compton D.R., Gold L.H., Ward S.J., Balster R.L., Martin B.R. J. Pharmacol. Exp. Ther. 263:1992;1118-1126.
6. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Science. 258:1992;1946-1949.
7. Mechoulam R., Ben Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., Vogel Z. Biochem. Pharmacol. 50:1995;83-90.
8. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Nature. 346:1990;561-564.
9. Munro S., Thomas K.L., Abu-Shaar M. Nature. 365:1993;61-65.
10. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Neuroscience. 83:1998;393-411.
11. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., le Fur G., Casellas P. Eur. J. Biochem. 232:1995;54-61.
12. Kaminski N.E. Adv. Exp. Med. Biol. 335:1993;115-120.
13. Howlett A.C., Qualy J.M., Khachatrian L.L. Mol. Pharmacol. 29:1986;307-313.
14. Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A.L., Mitchell R.L. Mol. Pharmacol. 48:1995;443-450.
15. Baldwin J.M. Curr. Opin. Cell Biol. 6:1994;180-190.
16. Strader C.D., Fong T.M., Tota M.R., Underwood D., Dixon R.A. Annu. Rev. Biochem. 63:1994;101-132.
17. van Rhee A.M., Jacobson K.A. Drug Dev. Res. 37:1996;1-38.
18. von Heijne G. J. Mol. Biol. 218:1991;499-503.
19. MacArthur M.W., Thornton J.M. J. Mol. Biol. 218:1991;397-412.
20. Williams K.A., Deber C.M. Biochemistry. 30:1991;8919-8923.
21. Huang R.R., Huang D., Strader C.D., Fong T.M. Biochemistry. 34:1995;16467-16472.
22. Hunyady L., Bor M., Balla T., Catt K.J. J. Biol. Chem. 270:1995;9702-9705.
23. Ballesteros J.A., Weinstein H.W. Methods Neurosci. 25:1995;366-428.
24. Bramblett R.D., Panu A.M., Ballesteros J.A., Reggio P.H. Life Sci. 56:1995;1971-1982.
25. Song Z.H., Slowey C.A., Hurst D.P., Reggio P.H. Mol. Pharmacol. 56:1999;834-840.
26. Chen C., Okayama H. Mol. Cell Biol. 7:1987;2745-2752.
27. DeBlasi A., O'Reilly K., Motulsky H.J. Trends Pharmacol. Sci. 10:1989;227-229.
28. Cheng Y., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099-3108.
29. Howlett A.C., Song C., Berglund B.A., Wilken G.H., Pigg J.J. Mol. Pharmacol. 53:1998;504-510.